BioSpace News Archive

Drug Development

Vertex Pharmaceuticals (MA) Release: Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis

November 7, 2011
·
1 min read
Drug Development

Galapagos NV to Present Results for Selective JAK1 Inhibitor in Rheumatoid Arthritis Patients on 22 November 2011

November 7, 2011
·
4 min read
Deals

China National Biotech Group to IPO on the Hong Kong Exchange

November 7, 2011
·
1 min read
Business

SterilMed Names Mike Gustafson Company President

November 7, 2011
·
1 min read
The Week in Review: Roche’s China Strategy

November 7, 2011
·
1 min read
Drug Development

CureVac GmbH Presents Results of a Phase I/IIa Trial in Non-Small Cell Lung Cancer (NSCLC) with CV9201, an mRNA Based Cancer Vaccine, at the 26th Annual SITC Meeting in Washington

November 7, 2011
·
2 min read
BIOTRONIK Presents New Economic Model: Remote Monitoring Reduces Hospital Workload and Healthcare Costs for Patients with Cardiac Implantable Electrical Devices

November 7, 2011
·
1 min read
Business

Horizon Discovery Ltd. Announces Strategic Partnership with Promega Corporation to Develop Next-Generation Predictive Human Disease Models

November 7, 2011
·
4 min read
Deals

Oxford Immunotec Limited Release: Federal Supply Schedule (FSS) Contract Awarded to Oxford Diagnostic Laboratories® for T-SPOT®.TB Testing

November 7, 2011
·
1 min read
Business

Antitope, Announces Antibody Research Agreement with Therapure Biopharma Inc.

November 7, 2011
·
2 min read